Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla Q3 Preview: India’s third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Tuesday, January 28, ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla reported a net profit of ₹1,303 crore, marking a 15% increase compared to the same period last year.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Drugmaker Cipla expects its “diversified” business in the US to help sustain its growth in the region, at a time the US administration is holding back funding for a global HIV/AIDS programme ...

Cipla has received a new recommendation from brokerage Motilal Oswal Financial Services, indicating a potential upside of 8.69%. The target price is set at Rs 1550.0, while the price at the time of ...

Cipla's stock is priced at Rs 1397.20, reflecting a decrease of 1.01% for the day, with one-year returns recorded at 3.05%. Cipla's stock is priced at Rs 1399.45, reflecting a decrease of 0.85% for ...

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. The company stated that supply challenges related to Lanreotide ...

For the first nine months of FY25, Cipla's EBITDA margin stood at 26.9%, already above its full-year guidance of 24.5% to 25.5%.

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business.

Cipla Q3 Results: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from ...